Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited
TLX · ASX

Telix Pharmaceuticals Limited

AU$16.67

Price Arrow0.15 (0.908%)
27/10/2025 04:10:29 PM
All-CompaniesAll-ConsensusALL-RecommendationsConsensus CheapEngulfing BearishGROWTH AUSHALO 100HALO 200+5
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Telix Pharmaceuticals Limited Overview

TLX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About TLX

icon

Telephone

61.3.9093.3855

icon

Address

North Melbourne, Suite 401, 55 Flemington Road, Melbourne, Victoria (VIC) 3051

Description

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

TLX Price Chart

Key Stats

Market Cap

AU$5.69B

PE

114.70

EV/EBITDA

72.7

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 13.3 - 31.97

Trade Value (12mth)

AU$9,906,091.00

1 week

0%

1 month

12.12%

YTD

-30.16%

1 year

-20.33%

All time high

31.97

Key Fundamentals

EPS 3 yr Growth

-152.80%

EBITDA Margin

11.50%

Operating Cashflow

$43m

Free Cash Flow Return

6.70%

ROIC

7.70%

Interest Coverage

4.20

Quick Ratio

2.70

Other Data

Shares Outstanding (Fully Diluted)

337m

HALO Sector

Healthcare

Next Company Report Date

19-Feb-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.26

TLX Announcements

Latest Announcements

DateAnnouncements
24 October 25
14 October 25
10 October 25
10 October 25
10 October 25

TLX Fundamentals

Per Share Records

Historical data

Forecast data

AUD2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.340.020.15locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.340.020.14locklocklock
Growth
%locklocklocklock-17.4104.9824.5locklocklock
PE
XlocklocklocklockN/A118.8114.7locklocklock
EV/EBITDA
XlocklocklocklockN/A50.672.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

8.69%

Value ($M)

453

Prior Change

0.1

7 Day Change

0.40%

1 Month Change

2.60%

3 Months Change

3.60%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

TLX Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Telix Pharmaceuticals Limited (TLX:ASX)?
Halo FAQ
The current share price of Telix Pharmaceuticals Limited (TLX:ASX) is AUD$16.67.
What is the 52-week high share price for Telix Pharmaceuticals Limited (TLX:ASX)?
Halo FAQ
The 52-week high share price for Telix Pharmaceuticals Limited (TLX:ASX) is AUD$31.97.
What is the 52-week low share price for Telix Pharmaceuticals Limited (TLX:ASX)?
Halo FAQ
The 52-week low share price for Telix Pharmaceuticals Limited (TLX:ASX) is AUD$13.30.
What is the dividend yield for Telix Pharmaceuticals Limited (TLX:ASX)?
Halo FAQ
Telix Pharmaceuticals Limited (TLX:ASX) does not pay a dividend.
What was Telix Pharmaceuticals Limited (TLX:ASX) last dividend payment?
Halo FAQ
Telix Pharmaceuticals Limited (TLX:ASX) does not pay a dividend.
What is the franking level for Telix Pharmaceuticals Limited (TLX:ASX)?
Halo FAQ
Telix Pharmaceuticals Limited (TLX:ASX) has a franking level of 0.00%.
In which sector is Telix Pharmaceuticals Limited (TLX:ASX) classified?
Halo FAQ
Telix Pharmaceuticals Limited (TLX:ASX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Telix Pharmaceuticals Limited (TLX:ASX)?
Halo FAQ
The current P/E ratio for Telix Pharmaceuticals Limited (TLX:ASX) is 114.70.

See beyond the curve.

One solution for research, investing and portfolio management.